Predictors of early response to onabotulinumtoxin type a in chronic migraine

被引：0
|
作者：
Mas-Sala, N. [1 ]
Quintana, M. [1 ]
Alvarez-Sabin, J. [1 ]
Pozo-Rosich, P. [1 ]
机构：
[1] Hosp Univ Vall Hebron, Neurol, Barcelona, Spain
来源：
JOURNAL OF HEADACHE AND PAIN | 2014年 / 15卷
关键词：
Migraine; Early Response; Chronic Migraine; Headache Frequency; Episodic Migraine;
D O I：
10.1186/1129-2377-15-S1-G31
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EHMTI-0283
引用
收藏
页数：1
相关论文
共 50 条
  • [41] ONABOTULINUMTOXIN A AS ONE OF THE PREVENTIVE TREATMENTS FOR CHRONIC MIGRAINE IN KOREAN ADOLESCENTS
    Choi, Y.
    Bae, C.
    CEPHALALGIA, 2016, 36 : 17 - 18
  • [42] Technique of injection of onabotulinumtoxin A for chronic migraine: the PREEMPT injection paradigm
    Liberini, P.
    Pari, E.
    Gazzina, S.
    Caratozzolo, S.
    Rao, R.
    Padovani, A.
    NEUROLOGICAL SCIENCES, 2014, 35 : S41 - S43
  • [43] Catastrophizing attitude changes after onabotulinumtoxin A treatment in chronic migraine
    Grazzi, Licia
    Grignani, Eleonora
    Sansone, Emanuela
    Raggi, Alberto
    D'Amico, Domenico
    Andrasik, Frank
    NEUROLOGICAL SCIENCES, 2019, 40 (Suppl 1) : S201 - S202
  • [44] Technique of injection of onabotulinumtoxin A for chronic migraine: the PREEMPT injection paradigm
    P. Liberini
    E. Pari
    S. Gazzina
    S. Caratozzolo
    R. Rao
    A. Padovani
    Neurological Sciences, 2014, 35 : 41 - 43
  • [45] Characteristics of onabotulinumtoxin-a responder among chronic migraine patients
    Lee, M.
    Lee, C.
    Chung, C. S.
    CEPHALALGIA, 2015, 35 : 50 - 50
  • [46] Experience with onabotulinumtoxin type a in high-frequency episodic migraine
    Pozo-Rosich, P.
    Quintana, M.
    Alvarez-Sabin, J.
    Mas Sala, N.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [47] Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: A retrospective study
    Lin, Kuan-Hsiang
    Chen, Shih-Pin
    Fuh, Jong-Ling
    Wang, Yen-Feng
    Wang, Shuu-Jiun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (01) : 10 - 15
  • [48] Long-term response to onabotulinumtoxin A in chronic migraine: analysis of efficacy and tolerability in a series of 40 patients
    Garcia-Azorin, D.
    Sierra, A.
    Trigo, J.
    Martinez-Pias, E.
    Guerrero, A. L.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [49] Neurophysiological, biomolecular and psychological predictors of response to Erenumab in chronic migraine
    Fiamingo, G.
    De Icco, R.
    Greco, R.
    Zanaboni, A. M.
    Bottiroli, S.
    Guaschino, E.
    Allena, M.
    Grillo, V.
    Tassorelli, C.
    Sancess, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 612 - 612
  • [50] Predictors of a negative response to topiramate therapy in patients with chronic migraine
    Rothrock, JF
    Parada, VA
    Drinkard, R
    Zweifler, RM
    Key, KE
    HEADACHE, 2005, 45 (07): : 932 - 935
12345